HIV infection
The sponsor’s clinical research activity is centered on HIV infection, with a focus on antiretroviral therapy strategies that support long-term treatment control and virological suppression.
- Maintenance antiretroviral therapy
- Long-acting treatment approaches
- Dual therapy
Its research interest includes therapeutic options designed to address ongoing management of HIV in adult patients, with attention to sustained viral control.
Long-acting antiviral agents
The sponsor is involved in studies of long-acting antiviral agents, reflecting an interest in treatments that may reduce reliance on frequent administration while maintaining disease control.
- Cabotegravir
- Lenacapavir
- Intramuscular administration
This area aligns with clinical evaluation of sustained-release regimens for people living with HIV.
Virological monitoring
Clinical interest extends to virological monitoring and the assessment of treatment durability, with emphasis on maintaining viral suppression over time.
- Virological failure
- Viral load assessment
- Treatment persistence
These topics support evaluation of how well antiretroviral regimens control HIV replication in routine clinical use.
Multicenter infectious disease research
The sponsor’s work includes multicenter clinical research in infectious diseases, involving collaborative sites in France and coordinated patient follow-up.
- Collaborative research sites
- Clinical follow-up
- Adult HIV care
This setting supports focused evaluation of treatment strategies within a specialized epidemiology and clinical research environment.
